• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Adjuvants in influenza vaccines

tetano

Editor, Senior Moderator
Vaccine. 2012 Oct 18. pii: S0264-410X(12)01453-3. doi: 10.1016/j.vaccine.2012.10.007. [Epub ahead of print]
Adjuvants in influenza vaccines.
Tetsutani K, Ishii KJ.
Source

Laboratory of Adjuvant Innovation, National Institute of Biomedical Innovation, Japan. Electronic address: tetztani@gmail.com.
Abstract

The effectiveness of influenza vaccines is still controversial, and the role of adjuvants in such vaccines is briefly reviewed in this paper. Inactivated whole virus vaccines may include components that function as adjuvants, meaning that additive adjuvants are often not required. MF59 and AS03 showed higher adjuvanticity than aluminum salts in several clinical studies. Recent research has suggested that immune cell recruitment is the main mechanism underlying adjuvant actions in general, and that aluminum salts induce this recruitment via inflammation at the injected site. The aspect of how oil-based adjuvants, such as MF59 and AS03, recruit immune cells remains to be clarified.

Copyright ? 2012. Published by Elsevier Ltd.

PMID:
23084848
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23084848
 
Back
Top Bottom